Waterford, Ireland

John Gerard O'Brien

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: John Gerard O'Brien: Innovator in Pediatric Dosage Forms

Introduction

John Gerard O'Brien is a notable inventor based in Waterford, Ireland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of pediatric dosage forms. With a total of three patents to his name, O'Brien's work focuses on improving the administration of vitamin D compounds for children.

Latest Patents

O'Brien's latest patents include innovative methods for creating pediatric and modified release dosage forms of vitamin D compounds. These patents detail the processes of making and using these dosage forms, which are crucial for ensuring that children receive the appropriate amounts of essential vitamins in a safe and effective manner.

Career Highlights

Throughout his career, John Gerard O'Brien has been associated with Eirgen Pharma Ltd., where he has played a vital role in advancing pharmaceutical formulations. His expertise in pediatric medicine has positioned him as a key figure in the development of specialized dosage forms that cater to the unique needs of children.

Collaborations

O'Brien has collaborated with esteemed colleagues such as Praful Balavant Deshpande and Stephen James Quinlan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical industry.

Conclusion

John Gerard O'Brien's contributions to pediatric dosage forms highlight his commitment to improving children's health through innovative pharmaceutical solutions. His work continues to impact the field positively, ensuring that young patients receive the best possible care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…